The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
FOCUS ON RESEARCH

PreviousPrevious
Volume 355:1195-1197 September 21, 2006 Number 12
NextNext

Telomeres, Telomerase, and Human Disease
Steven E. Artandi, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Telomeres, the genetic segments that appear at a chromosome's ends, have been known since the 1930s to have special properties that protect these ends. They were first isolated in the 1970s and 1980s and shown to be made up of DNA repeats that, when transferred to the ends of artificial chromosomes in yeast, could protect them from degradation. At the same time, a newly discovered enzyme called telomerase was found to add telomere repeats to the ends of chromosomes with the use of a dedicated RNA template. This mechanism of telomere addition by telomerase solved the "end-replication problem" — the . . . [Full Text of this Article]


Source Information

Dr. Artandi is an assistant professor of hematology at the Stanford University School of Medicine, Stanford, CA.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.